We will pay particular attention to those TFs implicated in cell fate and differentiation in the developing brain and how dysregulation of these TF programs following acquisition of a mutational load in brain tumors may serve to drive differential outcomes by driving TF-specific genetic programs and global expression changes. This evidence concerns the gene TF and brain neoplasm.